59 related articles for article (PubMed ID: 23059145)
1. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
Nave AM; Tolin DF; Stevens MC
J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
[TBL] [Abstract][Full Text] [Related]
2. Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence.
Prisciandaro JJ; Myrick H; Henderson S; McRae-Clark AL; Santa Ana EJ; Saladin ME; Brady KT
Drug Alcohol Depend; 2013 Sep; 132(1-2):195-201. PubMed ID: 23497788
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput clinical assay for testing drug facilitation of exposure therapy.
Rodebaugh TL; Levinson CA; Lenze EJ
Depress Anxiety; 2013 Jul; 30(7):631-7. PubMed ID: 23283838
[TBL] [Abstract][Full Text] [Related]
4. Examining the efficacy of d-cycloserine to augment therapeutic learning in depression.
Otto MW; Lee J; Hofmann SG; Hearon BA; Smits JA; Rosenfield D; Fava M; Wright JH
Contemp Clin Trials; 2016 May; 48():146-52. PubMed ID: 27094721
[TBL] [Abstract][Full Text] [Related]
5. Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.
Smits JA; Kauffman BY; Lee-Furman E; Zvolensky MJ; Otto MW; Piper ME; Powers MB; Rosenfield D
Contemp Clin Trials; 2016 May; 48():46-51. PubMed ID: 27015966
[TBL] [Abstract][Full Text] [Related]
6. More than fear? Brain activation patterns of dental phobic patients before and after an exposure-based treatment.
Wannemueller A; Margraf J; Busch M; Jöhren HP; Suchan B
J Neural Transm (Vienna); 2024 Apr; 131(4):393-404. PubMed ID: 38424282
[TBL] [Abstract][Full Text] [Related]
7. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
[TBL] [Abstract][Full Text] [Related]
8. Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.
Rodrigues H; Figueira I; Lopes A; Gonçalves R; Mendlowicz MV; Coutinho ES; Ventura P
PLoS One; 2014; 9(7):e93519. PubMed ID: 24991926
[TBL] [Abstract][Full Text] [Related]
9. The effect of d-cycloserine on brain processing of breathlessness over pulmonary rehabilitation: an experimental medicine study.
Finnegan SL; Harrison OK; Booth S; Dennis A; Ezra M; Harmer CJ; Herigstad M; Guillaume B; Nichols TE; Rahman NM; Reinecke A; Renaud O; Pattinson KTS
ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 37020840
[TBL] [Abstract][Full Text] [Related]
10. A randomized pharmacological fMRI trial investigating D-cycloserine and brain plasticity mechanisms in learned pain responses.
Thomaidou MA; Blythe JS; Veldhuijzen DS; Peerdeman KJ; van Lennep JHPA; Giltay EJ; Cremers HR; Evers AWM
Sci Rep; 2022 Nov; 12(1):19080. PubMed ID: 36351953
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
Garakani A; Murrough JW; Freire RC; Thom RP; Larkin K; Buono FD; Iosifescu DV
Front Psychiatry; 2020; 11():595584. PubMed ID: 33424664
[TBL] [Abstract][Full Text] [Related]
12. Unconscious Psychological Treatments for Physiological Survival Circuits.
Taschereau-Dumouchel V; Liu KY; Lau H
Curr Opin Behav Sci; 2018 Dec; 24():62-68. PubMed ID: 30480060
[TBL] [Abstract][Full Text] [Related]
13. A precision medicine approach to pharmacological adjuncts to extinction: a call to broaden research.
King G; Baker KD; Bisby MA; Chan D; Cowan CSM; Stylianakis AA; Zimmermann KS; Richardson R
Psychopharmacology (Berl); 2019 Jan; 236(1):143-161. PubMed ID: 30116858
[TBL] [Abstract][Full Text] [Related]
14. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
[TBL] [Abstract][Full Text] [Related]
15. D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.
Bürkner PC; Bittner N; Holling H; Buhlmann U
PLoS One; 2017; 12(3):e0173660. PubMed ID: 28282427
[TBL] [Abstract][Full Text] [Related]
16. d-Cycloserine enhances durability of social skills training in autism spectrum disorder.
Wink LK; Minshawi NF; Shaffer RC; Plawecki MH; Posey DJ; Horn PS; Adams R; Pedapati EV; Schaefer TL; McDougle CJ; Swiezy NB; Erickson CA
Mol Autism; 2017; 8():2. PubMed ID: 28138381
[TBL] [Abstract][Full Text] [Related]
17. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
McGuire JF; Wu MS; Piacentini J; McCracken JT; Storch EA
J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
Otto MW; Kredlow MA; Smits JAJ; Hofmann SG; Tolin DF; de Kleine RA; van Minnen A; Evins AE; Pollack MH
Biol Psychiatry; 2016 Aug; 80(4):274-283. PubMed ID: 26520240
[TBL] [Abstract][Full Text] [Related]
19. Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site.
Lench AM; Robson E; Jones RS
PLoS One; 2015; 10(7):e0133548. PubMed ID: 26193112
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
